Global and Europe Human Milk Oligosaccharides (HMO) Market Professional Survey Report 2019

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces.Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

    The Global Human Milk Oligosaccharides (HMO) market was valued at XX.0 million US$ in 2018, with the CAGR of 6.3%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Human Milk Oligosaccharides (HMO) market. Describe product range of Human Milk Oligosaccharides (HMO), market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Human Milk Oligosaccharides (HMO) market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Human Milk Oligosaccharides (HMO) market.

     

    By Player

    • Jennewein Biotechnologie

    • Dextra Laboratories

    • Inbiose

    • Glycom

    • ZuChem

    • Elicityl SA

    By Type

    • Neutral

    • Acidic

    • Other

    By End-User

    • Infant formula

    • Functional food & beverages

    • Food supplements

    • Others

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Human Milk Oligosaccharides (HMO) Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Neutral from 2014 to 2026

      • 1.3.2 Global Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Acidic from 2014 to 2026

      • 1.3.3 Global Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Infant formula from 2014 to 2026

      • 1.4.2 Global Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Functional food & beverages from 2014 to 2026

      • 1.4.3 Global Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Food supplements from 2014 to 2026

      • 1.4.4 Global Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Human Milk Oligosaccharides (HMO) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Human Milk Oligosaccharides (HMO) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Human Milk Oligosaccharides (HMO) Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Human Milk Oligosaccharides (HMO) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Human Milk Oligosaccharides (HMO) by Major Types

      • 3.4.1 Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Neutral

      • 3.4.2 Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Acidic

      • 3.4.3 Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Other

    4 Segmentation of Human Milk Oligosaccharides (HMO) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Human Milk Oligosaccharides (HMO) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Human Milk Oligosaccharides (HMO) for Infant formula

      • 4.4.2 Market Size and Growth Rate of Human Milk Oligosaccharides (HMO) for Functional food & beverages

      • 4.4.3 Market Size and Growth Rate of Human Milk Oligosaccharides (HMO) for Food supplements

      • 4.4.4 Market Size and Growth Rate of Human Milk Oligosaccharides (HMO) for Others

    5 Market Analysis by Major Regions

    • 5.1 Global Human Milk Oligosaccharides (HMO) Production Analysis by Top Regions

    • 5.2 Global Human Milk Oligosaccharides (HMO) Consumption Analysis by Top Regions

    • 5.3 Global Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    6 Product Circulation of Human Milk Oligosaccharides (HMO) Market among Top Countries

    • 6.1 Top 5 Export Countries in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 7.1 North America Human Milk Oligosaccharides (HMO) Landscape Analysis by Top Countries

      • 7.1.1 United States Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 7.1.2 Canada Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 7.1.3 Mexico Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

    8. Europe Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 8.1 Europe Human Milk Oligosaccharides (HMO) Landscape Analysis by Major Types

    • 8.2 Europe Human Milk Oligosaccharides (HMO) Landscape Analysis by Major End-Users

    • 8.3 Europe Human Milk Oligosaccharides (HMO) Landscape Analysis by Top Countries

      • 8.3.1 Germany Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.2 UK Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.3 France Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.4 Italy Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.5 Spain Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.6 Belgium Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.7 Poland Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.8 Russia Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.9 Turkey Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.10 Netherlands Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.11 Portugal Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.12 Denmark Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.13 Finland Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.14 Iceland Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.15 Norway Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 8.3.16 Sweden Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 9.1 Asia Pacific Human Milk Oligosaccharides (HMO) Landscape Analysis by Top Countries

      • 9.1.1 China Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 9.1.2 Japan Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 9.1.4 India Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 9.1.5 ASEAN Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 9.1.6 South Korea Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

    10 LAMEA Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 10.1 LAMEA Human Milk Oligosaccharides (HMO) Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 10.1.2 Brazil Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 10.1.3 North Africa Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 10.1.4 South Africa Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 10.1.5 Argentina Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Jennewein Biotechnologie

      • 11.1.1 Jennewein Biotechnologie Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Dextra Laboratories

      • 11.2.1 Dextra Laboratories Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Inbiose

      • 11.3.1 Inbiose Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Glycom

      • 11.4.1 Glycom Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 ZuChem

      • 11.5.1 ZuChem Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Elicityl SA

      • 11.6.1 Elicityl SA Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 113 Figures and 163 Tables)

    • Figure Product Picture

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Neutral from 2014 to 2026

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Acidic from 2014 to 2026

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Global Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Infant formula from 2014 to 2026

    • Figure Global Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Functional food & beverages from 2014 to 2026

    • Figure Global Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Food supplements from 2014 to 2026

    • Figure Global Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Others from 2014 to 2026

    • Figure North America Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure United States Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure UK Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure France Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure China Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure India Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Human Milk Oligosaccharides (HMO) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Human Milk Oligosaccharides (HMO)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Human Milk Oligosaccharides (HMO) by Different Types from 2014 to 2026

    • Table Consumption Share of Human Milk Oligosaccharides (HMO) by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Neutral

    • Figure Market Size and Growth Rate of Acidic

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Human Milk Oligosaccharides (HMO) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Human Milk Oligosaccharides (HMO) by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Infant formula

    • Figure Market Size and Growth Rate of Functional food & beverages

    • Figure Market Size and Growth Rate of Food supplements

    • Figure Market Size and Growth Rate of Others

    • Table Global Human Milk Oligosaccharides (HMO) Production by Major Regions

    • Table Global Human Milk Oligosaccharides (HMO) Production Share by Major Regions

    • Table Global Human Milk Oligosaccharides (HMO) Consumption by Major Regions

    • Table Global Human Milk Oligosaccharides (HMO) Consumption Share by Major Regions

    • Table North America Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table Europe Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table LAMEA Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Human Milk Oligosaccharides (HMO) Consumption by Major Countries from 2014 to 2026

    • Table North America Human Milk Oligosaccharides (HMO) Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Human Milk Oligosaccharides (HMO) Consumption Share by Major Countries in 2014

    • Figure North America Human Milk Oligosaccharides (HMO) Consumption Share by Major Countries in 2018

    • Figure North America Human Milk Oligosaccharides (HMO) Consumption Share by Major Countries in 2026

    • Figure United States Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Human Milk Oligosaccharides (HMO) Consumption by Types from 2014 to 2026

    • Table Europe Human Milk Oligosaccharides (HMO) Consumption Share by Types from 2014 to 2026

    • Table Europe Human Milk Oligosaccharides (HMO) Consumption by End-Users from 2014 to 2026

    • Table Europe Human Milk Oligosaccharides (HMO) Consumption Share by End-Users from 2014 to 2026

    • Table Europe Human Milk Oligosaccharides (HMO) Consumption by Major Countries from 2014 to 2026

    • Table Europe Human Milk Oligosaccharides (HMO) Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure France Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Human Milk Oligosaccharides (HMO) Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Human Milk Oligosaccharides (HMO) Consumption Share by Major Countries from 2014 to 2026

    • Figure China Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure India Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Jennewein Biotechnologie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jennewein Biotechnologie

    • Figure Sales and Growth Rate Analysis of Jennewein Biotechnologie

    • Figure Revenue and Market Share Analysis of Jennewein Biotechnologie

    • Table Product and Service Introduction of Jennewein Biotechnologie

    • Table Company Profile and Development Status of Dextra Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dextra Laboratories

    • Figure Sales and Growth Rate Analysis of Dextra Laboratories

    • Figure Revenue and Market Share Analysis of Dextra Laboratories

    • Table Product and Service Introduction of Dextra Laboratories

    • Table Company Profile and Development Status of Inbiose

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Inbiose

    • Figure Sales and Growth Rate Analysis of Inbiose

    • Figure Revenue and Market Share Analysis of Inbiose

    • Table Product and Service Introduction of Inbiose

    • Table Company Profile and Development Status of Glycom

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glycom

    • Figure Sales and Growth Rate Analysis of Glycom

    • Figure Revenue and Market Share Analysis of Glycom

    • Table Product and Service Introduction of Glycom

    • Table Company Profile and Development Status of ZuChem

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ZuChem

    • Figure Sales and Growth Rate Analysis of ZuChem

    • Figure Revenue and Market Share Analysis of ZuChem

    • Table Product and Service Introduction of ZuChem

    • Table Company Profile and Development Status of Elicityl SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Elicityl SA

    • Figure Sales and Growth Rate Analysis of Elicityl SA

    • Figure Revenue and Market Share Analysis of Elicityl SA

    • Table Product and Service Introduction of Elicityl SA

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.